Samsung Bioepis Co., Ltd. vs. Regeneron Pharmaceuticals, Inc.
Explore the PTAB proceeding IPR2023-00739 filed by Samsung Bioepis Co., Ltd. on 2023-03-26. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-00739
Filing Date
2023-03-26
Accorded Filing Date
2023-03-27
Institution Decision Date
2023-10-20
Last Modified Date
2025-03-26
Proceeding Type
IPR
Termination Date
2024-07-30
Trial Status
Terminated-Adverse Judgment
Parties & Counsel
Petitioner
Samsung Bioepis Co., Ltd.
Represented By
Nimrod, Raymondet alPatent Owner / Respondent
Regeneron Pharmaceuticals, Inc.
Represented By
Brausa, Adamet alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Respondent Application Number
16397267
Respondent Patent Number
10888601
External Links
Respondent Inventor
George D. YANCOPOULOS
Respondent Tech Center
TC 1600 - Biotechnology & Organic Chemistry
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Firm
/ Entity Name
A&P - Regeneron (Prosecution)
Customer
Number
191459
Address
601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 41408 | David Marsh | 202-942-5068 |
| 48001 | Thomas Triolo | 914-847-1612 |
| 48921 | Stephen Gaudet | 914-847-7376 |
| 50370 | Neil Miyamoto | 914-847-7175 |
| 50437 | Frank Cottingham | 914-593-1116 |
| 58583 | Brian Cocca | 914-847-1421 |
| 58714 | Ilona Gont | 914-847-1304 |
| 59668 | Brandon Schurter | 914-847-7000 |
Proceeding Documents
200
59
Order: Granting Patent Owners Motion to Expunge 37 C.F.R. sec. 42.56 ORDER
2024-10-08
FILING PARTY: BOARD
2043
Ex. 2043 - Manning Declaration - Redacted Exhibit
2024-09-04
FILING PARTY: PATENT OWNER
58
Patent Owner's Motion to Expunge MOTION
2024-09-04
FILING PARTY: PATENT OWNER
57
Adverse judgment: post-institution ADVRSJUDG
2024-07-30
FILING PARTY: BOARD
3003
Ex. 3003 Exhibit
2024-07-18
FILING PARTY: BOARD